Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Two Distinct Co-Culture Systems, Designed to Mimic the Tumor Microenvironment, Induce Remarkably Similar Phenotypic Changes in Primary CLL Cells.

Andrea Gail Sherman Buggins, Ph.D., Laurence Pearce, B.Sc, Piers EM Patten, BSc, MRCP, MRCPath, Liam Morgan, Paul Brennan, Chris Fegan, Stephen Devereux, FRCP, FRCPath, Chris J Pepper

Blood (2009) 114 (22): 2362.

https://doi.org/10.1182/blood.V114.22.2362.2362

Published: 2009

Journal Articles

Increased Effector CD4 + T-Cells Early Post Hematopoietic Stem Cell Transplantation Using an Alemtuzumab-Based Reduced Intensity Conditioning Regimen Correlate with Subsequent Development of Graft Versus Host Disease.

Katie Matthews, PhD, ZiYi Lim, MD, Laurence Pearce, Msc, Khalid Tobal, PhD, Alejandro Madrigal, MD, PhD, Ghulam J. Mufti, MD, Linda D. Barber, PhD

Blood (2007) 110 (11): 4999.

https://doi.org/10.1182/blood.V110.11.4999.4999

Published: 2007

Journal Articles

Progression Free Survival (PFS) in Alemtuzumab Based RIC Allogeneic Transplantation for Myeloma Is Improved with Use of Pre-Emptive DLI (pDLI).

Karthik Ramasamy, MD, Shameem Mahmood, MD, Laurence Pearce, MD, ZiYi Lim, MD, Dariusz Ladon, PhD, Antonio Pagliuca, MD, Stephen Devereux, MD, PhD, Ghulam J. Mufti, MD, DM, Stephen Schey, MD

Blood (2007) 110 (11): 3034.

https://doi.org/10.1182/blood.V110.11.3034.3034

Published: 2007

Journal Articles

In-Situ Proliferation May Explain the Persistence of Host Derived Langerhans Cells Following Allogeneic Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning.

Julie Richards, PhD, Laurence Pearce, BSc, Piers E.M. Patten, MD, Andrea G.S. Buggins, PhD, Aloyisius Y. Ho, MD, Anthony Pagliuca, MD, Ghulam J. Mufti, MD, Stephen Devereux, MD, PhD

Blood (2007) 110 (11): 1196.

https://doi.org/10.1182/blood.V110.11.1196.1196

Published: 2007

Journal Articles

Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and Lower Incidence of Acute Graft Versus Host Disease.

ZiYi Lim, Murugaiyan Thanigaikumar, Shreyans Gandhi, Laurence Pearce, Michelle Kenyon, Aloysius Y.L. Ho, Stephen Devereux, Antonio Pagliuca, Ghulam J. Mufti

Blood (2007) 110 (11): 1994.

https://doi.org/10.1182/blood.V110.11.1994.1994

Published: 2007

Journal Articles

The Pattern of T-Cell Donor Chimerism Is a Key Predictor of Outcome Following Alemtuzumab Based Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for MDS and AML.

ZiYi Lim, Laurence Pearce, Aloysius Y.L. Ho, Linda Barber, Wendy Ingram, Monica Usai, Stephen Devereux, Antonio Pagliuca, Ghulam Mufti

Blood (2006) 108 (11): 42.

https://doi.org/10.1182/blood.V108.11.42.42

Published: 2006

Journal Articles

Use of Pre-Emptive Donor Lymphocyte Infusions To Achieve Durable Remission Following Alemtuzumab Based Reduced Intensity Conditioning (RIC) Transplantation for AML or MDS.

ZiYi Lim, Laurence Pearce, Wendy Ingram, Rafael Duarte, Stephen Devereux, Antonio Pagliuca, Aloysius Ho, Ghulam Mufti

Blood (2005) 106 (11): 1124.

https://doi.org/10.1182/blood.V106.11.1124.1124

Published: 2005

Journal Articles

Matched Pair Analysis of Intravenous vs Oral Busulphan as Part of Fludarabine-Busulphan-Campath (Alemtuzumab) Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT).

ZiYi Lim, Dragana Milojkovic, Laurence Pearce, Michelle Kenyon, Aloysius Ho, Stephen Devereux, Antonio Pagliuca, Ghulam Mufti

Blood (2005) 106 (11): 1762.

https://doi.org/10.1182/blood.V106.11.1762.1762

Published: 2005

Journal Articles

The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells

Alex Tonks, Lorna Pearn, Amanda J. Tonks, Laurence Pearce, Terry Hoy, Sarah Phillips, Janet Fisher, James R. Downing, Alan K. Burnett, Richard L. Darley

Blood (2003) 101 (2): 624–632.

https://doi.org/10.1182/blood-2002-06-1732

Published: 2003

NARROW

Two Distinct Co-Culture Systems, Designed to Mimic the Tumor Microenvironment, Induce Remarkably Similar Phenotypic Changes in Primary CLL Cells.

Increased Effector CD4 + T-Cells Early Post Hematopoietic Stem Cell Transplantation Using an Alemtuzumab-Based Reduced Intensity Conditioning Regimen Correlate with Subsequent Development of Graft Versus Host Disease.

Progression Free Survival (PFS) in Alemtuzumab Based RIC Allogeneic Transplantation for Myeloma Is Improved with Use of Pre-Emptive DLI (pDLI).

In-Situ Proliferation May Explain the Persistence of Host Derived Langerhans Cells Following Allogeneic Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning.

Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and Lower Incidence of Acute Graft Versus Host Disease.

The Pattern of T-Cell Donor Chimerism Is a Key Predictor of Outcome Following Alemtuzumab Based Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for MDS and AML.

Use of Pre-Emptive Donor Lymphocyte Infusions To Achieve Durable Remission Following Alemtuzumab Based Reduced Intensity Conditioning (RIC) Transplantation for AML or MDS.

Matched Pair Analysis of Intravenous vs Oral Busulphan as Part of Fludarabine-Busulphan-Campath (Alemtuzumab) Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT).

The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only